Clinical Trial Update: A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study comparing abiraterone acetate capsule and tablet formulations in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostate Neoplasms | Phase 1 | Status: COMPLETED